dimethandrolone-undecanoate: Clinical Trials

3 trials of dimethandrolone-undecanoate, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed. 2 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 12Completed 2
Phase 21Completed 1

Follow dimethandrolone-undecanoate: new trials by email Literature Review of dimethandrolone-undecanoate trials Research Report on dimethandrolone-undecanoate

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study of Spermatogenesis Suppression With DMAU Alone or With LNG Versus Placebo Alone in Normal Men
Dimethandrolone-Undecanoate, Levonorgestrel 0.03 MG, Placebo oral capsule - Healthy, Men
Phase 2CompletedPremier Research922018-04-162025-10-30
Injectable DMAU for Male Contraception in Healthy Male Volunteers (CCN015)
Dimethandrolone Undecanoate, Placebo - Healthy Men, Male Contraception
Phase 1CompletedKimberly Myer1062017-02-152025-10-31
Phase 1 Study of Dimethandrolone Undecanoate in Healthy Men
Dimethandrolone Undecanoate, Placebo - Healthy Men, Male Contraception
Phase 1CompletedLundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center1002012-03-012025-11-20

Conditions studied

Multiple Endocrine Neoplasia Type 1 (1)

Sponsors

Kimberly Myer (1)  ·  Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center (1)  ·  Premier Research (1)

Countries

United States (3)

Top investigators

Christina Wang, MD (2)  ·  Stephanie Page Page, MD, PhD (1)  ·  Stephanie Page, MD (1)

Results publications

PMID 27907978, PMID 30252061, PMID 33090208, PMID 33908182